Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.

Abstract:

:The authors studied the expression of c-myc and ras family oncogene products in 43 cases of malignant lymphoma (ML) using the immunoperoxidase method. Unfixed frozen sections of lymph nodes from four patients with Hodgkin's disease and 39 with non-Hodgkin's lymphoma, together with normal lymph nodes, were studied by the avidin-biotin-peroxidase complex (ABC) technique. Two monoclonal antibodies, MYC-2 raised against recombinant human c-myc protein (reacting specifically with the c-myc products P62 and P67) and RASK-4 (raised against recombinant P21 and reacting specifically with ras-family product P21) were used. The c-myc product was detected in nuclei of ML cells and some normal, mainly germinal center, lymphocytes. When the staining intensity shown by normal germinal-center lymphocytes was graded as positive (+) or weakly positive (+/-), a very intensely positive reaction ( to ++) was observed in 37 cases (86%) of ML, a positive reaction (+) in four cases (9.3%), and a weakly positive reaction (+/-) in two cases (4.7%). The ras family oncogene product reaction was intensely positive (++) in two cases (4.7%), positive (+) in 16 cases (37.2%), weakly positive (+/-) in 13 cases (30.2%), and negative in 12 cases (27.9%). Western blot analysis confirmed an elevated level of c-myc products in two cases, which showed intense MYC-2 staining, and of ras family products in one case, which demonstrated intense RASK-4 staining. The enhanced expression of these gene products may play an important role in lymphomagenesis of such cases.

journal_name

Cancer

journal_title

Cancer

authors

Mitani S,Sugawara I,Shiku H,Mori S

doi

10.1002/1097-0142(19881115)62:10<2085::aid-cncr282

subject

Has Abstract

pub_date

1988-11-15 00:00:00

pages

2085-93

issue

10

eissn

0008-543X

issn

1097-0142

journal_volume

62

pub_type

杂志文章

相关文献

CANCER文献大全
  • Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens.

    abstract:BACKGROUND:Immunohistological markers specific for a single type of epithelium are rare. Recently, urothelium tissue-specific genes were cloned. The genes encoded a family of transmembrane proteins, uroplakins, that are expressed only in urothelial mucosa. Using uroplakin antibodies on paraffin-embedded tissue, a previ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.9032

    authors: Xu X,Sun TT,Gupta PK,Zhang P,Nasuti JF

    更新日期:2001-06-25 00:00:00

  • Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.

    abstract:BACKGROUND:Ligand activation of peroxisome proliferator-activated receptor gamma (PPARgamma) results in the inhibition of proliferation of various cancer cells. The aim of this study is to investigate the mechanisms of cell growth inhibition of hepatocellular carcinoma (HCC) cell lines by the PPARgamma ligand, troglita...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10906

    authors: Yoshizawa K,Cioca DP,Kawa S,Tanaka E,Kiyosawa K

    更新日期:2002-11-15 00:00:00

  • A proposed staging system for chronic myeloid leukemia.

    abstract::A staging system was proposed for chronic myeloid leukemia (CML) that groups patients into three stages (I, II, and III), each with two subclasses (A and B). The system uses pathologic parameters, of which the percentage of blasts in the blood and bone marrow is the most important. CML is defined as a myeloproliferati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930601)71:11<3788::aid-cncr282

    authors: Ross DW,Brunning RD,Kantarjian HM,Koeffler HP,Ozer H

    更新日期:1993-06-01 00:00:00

  • Thrombocytosis in patients with malignant pleural mesothelioma.

    abstract::Thrombocytosis above 40.0 X 10(4)/mm3 occurred in five of six (83%) patients with malignant mesothelioma. In contrast, the incidence of thrombocytosis was 7.5% in patients with lung adenocarcinoma, 12.5% in squamous cell carcinoma, 5.1% in small cell carcinoma, and 41.7% in large cell carcinoma, respectively. The plat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19861015)58:8<1699::aid-cncr2820

    authors: Nakano T,Fujii J,Tamura S,Hada T,Higashino K

    更新日期:1986-10-15 00:00:00

  • Retinitis pigmentosa and colon cancer: a previously unreported association.

    abstract::Retinitis pigmentosa, a hereditary disease characterized by progressive retinal degeneration and blindness, has been associated with numerous diseases. We report the first association between retinitis pigmentosa and colon cancer in 3 of 53 hospitalized patients with retinitis pigmentosa at the Massachusetts General H...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800601)45:11<2897::aid-cncr282

    authors: Winzelberg GG,Greenstein R,Ferrucci JT Jr

    更新日期:1980-06-01 00:00:00

  • Remission induction in adult acute lymphocytic leukemia. Use of vincristine and prednisone alone.

    abstract::Therapy for acute lymphocytic leukemia (ALL) has been less successful in adults than in children. Many centers treat all adult leukemia with the same regimen. We have used vincristine and prednisone for initial therapy in 14 adults with ALL since 1971 and have followed a treatment regimen developed for childhood ALL f...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197608)38:2<672::aid-cncr2820380

    authors: Scavino HF,George JN,Sears DA

    更新日期:1976-08-01 00:00:00

  • Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

    abstract:BACKGROUND:The optimal weekly oral dose of sirolimus and intravenous nanoparticle albumin-bound paclitaxel (nab-paclitaxel) were evaluated. METHODS:A phase 1b study was performed to evaluate escalating doses of oral sirolimus (5-60 mg) on days 2, 9, and 16 with intravenous nab-paclitaxel (100 mg/m(2) ) on days 1, 8, a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29254

    authors: Abu-Khalaf MM,Baumgart MA,Gettinger SN,Doddamane I,Tuck DP,Hou S,Chen N,Sullivan C,Lezon-Geyda K,Zelterman D,Hatzis C,Deshpande H,Digiovanna MP,Azodi M,Schwartz PE,Harris LN

    更新日期:2015-06-01 00:00:00

  • Racial segregation and disparities in breast cancer care and mortality.

    abstract:BACKGROUND:Questions have existed as to whether residential segregation is a mediator of racial/ethnic disparities in breast cancer care and breast cancer mortality, or has a differential effect by race/ethnicity. METHODS:Data from the Surveillance, Epidemiology, and End Results-Medicare database on white, black, and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23828

    authors: Haas JS,Earle CC,Orav JE,Brawarsky P,Keohane M,Neville BA,Williams DR

    更新日期:2008-10-15 00:00:00

  • OKM1-positive T-cell leukemias. Relationships among morphologic features, phenotype, and functional activities.

    abstract::The morphologic features, phenotype, and functions of OKM1+ leukemic T-cells were studied. The leukemic T-cells in two patients with chronic lymphocytic leukemia (CLL) had specific features of large granular lymphocytes (LGL), and those in two patients with acute lymphocytic leukemia (ALL) had L2 morphologic character...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860415)57:8<1507::aid-cncr2820

    authors: Tagawa S,Taniguchi N,Tokumine Y,Tamaki T,Konishi I,Kanayama Y,Inoue R,Machii T,Kitani T

    更新日期:1986-04-15 00:00:00

  • Prostaglandin-E-producing hepatocellular carcinoma with hypercalcemia.

    abstract::An autopsy case of prostaglandin E-producing hepatocellular carcinoma with hypercalcemia is presented in this article. A 72-year-old man showed high serum calcium levels (14.2 to 17.3 mg/100 ml) and hypophosphatemia. The plasma level of immunoreactive parathyroid hormone was below the normal range. Administration of o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880501)61:9<1813::aid-cncr2820

    authors: Ikeda T,Tozuka S,Hasumura Y,Takeuchi J

    更新日期:1988-05-01 00:00:00

  • A spectrum of cytomorphologic variations in medullary thyroid carcinoma. Fine-needle aspiration findings in 19 cases.

    abstract:BACKGROUND:Medullary thyroid carcinoma (MTC), a rare malignancy with a variety of morphologic appearances, can mimic both primary and metastatic lesions of the thyroid gland and give rise to diagnostic problems when these tumors are aspirated. Although cytopathologic features of MTC have been well described, this study...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Green I,Ali SZ,Allen EA,Zakowski MF

    更新日期:1997-02-25 00:00:00

  • Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.

    abstract:BACKGROUND:Many histologic classifications of thymic epithelial tumors have been reported to date, but to the authors' knowledge, none of them closely reflect the clinical behavior or prognosis of the tumor. Therefore, it is necessary to establish a biologic marker for thymic epithelial tumors. Variants of CD44 may be ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21046

    authors: Sonobe S,Miyamoto H,Nobukawa B,Izumi H,Futagawa T,Ishikawa N,Yamazaki A,Uekusa T,Abe H,Suda K

    更新日期:2005-05-15 00:00:00

  • Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects.

    abstract::Twenty-nine cases of non-Hodgkin's lymphoma of Waldeyer's ring (W-NHL) and nasal cavity or paranasal sinus (N-NHL) were studied for tumor-surface marker phenotype and histopathologic correlation with clinical features. Immunostaining procedures on tissue sections by using xenoantisera and monoclonal antibodies to huma...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850815)56:4<768::aid-cncr28205

    authors: Yamanaka N,Harabuchi Y,Sambe S,Shido F,Matsuda F,Kataura A,Ishii Y,Kikuchi K

    更新日期:1985-08-15 00:00:00

  • A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.

    abstract:BACKGROUND:The primary purpose of this study was to establish the maximum tolerated dose (MTD) of intravenous melphalan in combination with paclitaxel and cisplatin plus granulocyte-colony stimulating factor (G-CSF) in patients with suboptimal advanced epithelial ovarian carcinoma or primary peritoneal carcinoma. METH...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gershenson DM,Morris M,Burke TW,Levenback C,Wolf J,Lee JJ,Thall PF,Atkinson EN,Silva EG,Wharton JT

    更新日期:1999-12-01 00:00:00

  • Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.

    abstract:BACKGROUND:In patients with locoregional carcinoma of the esophagus or esophagogastric junction who underwent preoperative chemoradiation, it is unclear whether survival was better predicted by pretherapy clinical stage or by posttherapy pathologic stage. METHODS:The authors studied 235 consecutive patients with preth...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20916

    authors: Chirieac LR,Swisher SG,Ajani JA,Komaki RR,Correa AM,Morris JS,Roth JA,Rashid A,Hamilton SR,Wu TT

    更新日期:2005-04-01 00:00:00

  • Cytologic factors associated with prognosis in patients with peripheral adenocarcinoma of the lung measuring 3 cm or less in greatest dimension.

    abstract:BACKGROUND:Recently, peripheral lung adenocarcinomas (PLA) measuring < or = 3 cm in greatest dimension often have been diagnosed using diagnostic radiology. The objective of the current study was to determine which cytologic factors are associated with a favorable outcome and an unfavorable outcome in patients with PLA...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20686

    authors: Kobayashi Y,Yokose T,Kawamura K,Iwasaki S,Murata Y,Onuma S,Hasebe T,Nagai K,Sasaki S,Ochiai A

    更新日期:2005-02-25 00:00:00

  • Acute promyelocytic leukemia. A childhood cluster.

    abstract::Nine children with acute promyelocytic leukemia (APL) are presented. This series of children represents 7% of all acute leukemias and 21% of acute myelogenous leukemias seen during the same period at the Red Cross War Memorial Children's Hospital. These figures are much higher than the incidence quoted in other series...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870301)59:5<933::aid-cncr28205

    authors: Gilbert RD,Karabus CD,Mills AE

    更新日期:1987-03-01 00:00:00

  • Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.

    abstract:BACKGROUND:There is accumulating evidence that galanin receptors (GALRs) may be tumor suppressors in head and neck squamous cell carcinoma (HNSCC). Promoter methylation status and gene expression were assessed in a large panel of head and neck primary tumors, based on the hypothesis that cytosine-guanine dinucleotide (...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28411

    authors: Misawa Y,Misawa K,Kanazawa T,Uehara T,Endo S,Mochizuki D,Yamatodani T,Carey TE,Mineta H

    更新日期:2014-01-15 00:00:00

  • Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.

    abstract::Thymic carcinomas are rare malignant neoplasms of the thymic epithelium that are distinguished from the malignant thymomas by the presence of cytologic atypia. Thymic carcinomas may metastasize outside of the thorax and are associated with a very poor prognosis. Complete responses of thymic carcinoma to chemotherapy a...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,评审

    doi:10.1002/1097-0142(19901115)66:10<2092::aid-cncr282

    authors: Carlson RW,Dorfman RF,Sikic BI

    更新日期:1990-11-15 00:00:00

  • What do transplant physicians think about palliative care? A national survey study.

    abstract:BACKGROUND:Despite its established benefits, palliative care (PC) is rarely utilized for hematopoietic stem cell transplant (HSCT) patients. We sought to examine transplant physicians' perceptions of PC. METHODS:We conducted a cross-sectional survey of transplant physicians recruited from the American-Society-for-Bloo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31709

    authors: El-Jawahri A,LeBlanc TW,Burns LJ,Denzen E,Meyer C,Mau LW,Roeland EJ,Wood WA,Petersdorf E

    更新日期:2018-12-01 00:00:00

  • Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.

    abstract:BACKGROUND:Although state Medicaid programs cover cancer screening, Medicaid beneficiaries are less likely to be screened for cancer and are more likely to present with tumors of an advanced stage than are those with other insurance. The current study was performed to determine whether state Medicaid eligibility and re...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28704

    authors: Halpern MT,Romaire MA,Haber SG,Tangka FK,Sabatino SA,Howard DH

    更新日期:2014-10-01 00:00:00

  • Prognostic ability of simplified nuclear grading of renal cell carcinoma.

    abstract:BACKGROUND:The Fuhrman grading system is an established predictor of survival in patients with renal cell carcinoma (RCC). The predictive accuracy of various Fuhrman grading schemes was tested with the intent of improving the prediction of RCC-specific survival (RCC-SS). METHODS:The analyses targeted 5453 patients fro...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.22463

    authors: Rioux-Leclercq N,Karakiewicz PI,Trinh QD,Ficarra V,Cindolo L,de la Taille A,Tostain J,Zigeuner R,Mejean A,Patard JJ

    更新日期:2007-03-01 00:00:00

  • Imaging hepatic neoplasms.

    abstract::The various radiologic methods used in the detection of hepatic lesions in the oncologic patient are discussed. The advantages and disadvantages of each imaging technique as well as a new diagnostic approach are also discussed. With the rapid technological advances made in cross-sectional imaging, the authors believe ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Bernardino ME,Lewis E

    更新日期:1982-12-01 00:00:00

  • The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.

    abstract:BACKGROUND:The incidence, risk factors, time course, and impact on survival of venous thromboembolism (VTE) in a large, population-based study of patients with bladder cancer have not been identified previously. METHODS:The California Cancer Registry was merged with the California Patient Discharge Data Set to determi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25004

    authors: Sandhu R,Pan CX,Wun T,Harvey D,Zhou H,White RH,Chew HK

    更新日期:2010-06-01 00:00:00

  • Cancer care challenges in developing countries.

    abstract:BACKGROUND:Health systems in Sub-Saharan Africa are not prepared for the rapid rise in cancer rates projected in the region over the next decades. More must be understood about the current state of cancer care in this region to target improvement efforts. Yaounde General Hospital (YGH) currently is the only site in Cam...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26681

    authors: Price AJ,Ndom P,Atenguena E,Mambou Nouemssi JP,Ryder RW

    更新日期:2012-07-15 00:00:00

  • Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.

    abstract:BACKGROUND:Recently, adenomatous hyperplasia (AH) of the liver, a sizable parenchymal nodule in the cirrhotic liver, has been considered a preneoplastic lesion in human hepatocarcinogenesis. METHODS:The authors evaluated cell proliferative activity by immunostaining for proliferating cell nuclear antigen (PCNA) in AH ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920801)70:3<591::aid-cncr28207

    authors: Terada T,Nakanuma Y

    更新日期:1992-08-01 00:00:00

  • Laparoscopy and biopsy in malignant liver disease.

    abstract::Laparoscopy is highly effective in diagnosing malignant liver disease, with overall accuracy in the 90% range. Up to 80% of the liver surface can be inspected, and biopsies can be directed with precision. A major advantage over scan guided percutaneous techniques is the ability to detect and biopsy lesions only a few ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Lightdale CJ

    更新日期:1982-12-01 00:00:00

  • Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.

    abstract:BACKGROUND:Currently, no standard therapy exists for patients with relapsed and/or refractory non-Hodgkin lymphoma (NHL) who are ineligible for transplantation or who have failed after bone marrow transplantation. The authors of this report investigated the safety and efficacy of clofarabine (CLO) in these patients. M...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25603

    authors: Nabhan C,Davis N,Bitran JD,Galvez A,Fried W,Tolzien K,Foss S,Dewey WM,Venugopal P

    更新日期:2011-04-01 00:00:00

  • HLA-DR and differentiated thyroid cancer. Lack of association with the nonmedullary types and possible association with the medullary type.

    abstract::One hundred twenty-seven white European patients with differentiated thyroid cancer were typed for human lymphocyte antigen (HLA) DR specificities. There was no significant deviation from the HLA-DR distribution observed in 160 normal patient controls, neither in the entire group nor in the patient groups with nonmedu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19881215)62:12<2486::aid-cncr282

    authors: Weissel M,Kainz H,Hoefer R,Mayr WR

    更新日期:1988-12-15 00:00:00

  • Endometrial cancer: therapeutic decision and the staging process in "early" disease.

    abstract::An all inclusive, widely accepted system for correlation of indices of pathophysiology in endometrial cancer with a spectrum of therapeutic management has yet to be developed. Improved understanding of tumor growth should lead to more logical, individualized treatment especially in terms of irradiation. To support the...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(197702)39:2+<959::aid-cncr282039

    authors: Lewis GC Jr,Mortel R,Slack NH

    更新日期:1977-02-01 00:00:00